课题基金 / 基金详情

T cell subsets in inflammatory bowel disease

T cell subsets in inflammatory bowel disease
炎症性肠病中的 T 细胞亚群
批准号:
10364307
负责人:
John T Chang
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31

项目摘要

项目成果

John T Chang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary The inflammatory bowel diseases (IBD) are chronic, incurable conditions that contribute to significant morbidity and mortality in the Veteran population. Current therapies are effective long-term in only ~25% of patients with IBD, suggesting that as yet unknown immune cell subsets may be involved in the initial development and relapsing-remitting nature of IBD. We propose to elucidate T cell subsets that may play a role in the pathophysiology of IBD; this work may ultimately lead to new therapeutic targets for IBD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell subsets in inflammatory bowel disease
  • 批准号:
    10569030
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    John T Chang
  • 依托单位:
Transcriptional regulation of T cell immunity
  • 批准号:
    10341041
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    John T Chang
  • 依托单位:
Transcriptional regulation of T cell immunity
  • 批准号:
    10008141
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    John T Chang
  • 依托单位:
Transcriptional regulation of T cell immunity
  • 批准号:
    10618783
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    John T Chang
  • 依托单位:
海外基金